William Strohl

Person

Radnor, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
RAGE fusion proteins with improved stability and ligand binding aff...
- Patent number 11,535,661
- Issue date Dec 27, 2022
- BIOAGE LABS, INC.
- Robert Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors comprising BCMA-specific fibronectin typ...
- Patent number 11,096,998
- Issue date Aug 24, 2021
- Janssen Biotech, Inc.
- Chen Ni Chin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RAGE fusion proteins with improved stability and ligand binding aff...
- Patent number 10,913,784
- Issue date Feb 9, 2021
- BIOAGE LABS, INC.
- Robert Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody Fc mutants with ablated effector functions
- Patent number 10,894,836
- Issue date Jan 19, 2021
- Janssen Biotech, Inc.
- McCarthy Stephen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 10,106,617
- Issue date Oct 23, 2018
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for phagocyte delivery of anti-staphylococ...
- Patent number 10,087,243
- Issue date Oct 2, 2018
- New York University
- Victor J. Torres
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody Fc mutants with ablated effector functions
- Patent number 10,053,513
- Issue date Aug 21, 2018
- Janssen Biotech, Inc.
- Stephen McCarthy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 9,777,062
- Issue date Oct 3, 2017
- CSL Limited
- Andrew Donald Nash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for phagocyte delivery of anti-staphylococ...
- Patent number 9,644,023
- Issue date May 9, 2017
- New York University
- Victor J. Torres
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody Fc mutants with ablated effector functions
- Patent number 9,637,549
- Issue date May 2, 2017
- Janssen Biotech, Inc.
- William Strohl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Active protease-resistant antibody FC mutants
- Patent number 9,611,328
- Issue date Apr 4, 2017
- Janssen Biotech, Inc.
- Randall Brezski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 9,371,388
- Issue date Jun 21, 2016
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody Fc mutants with ablated effector functions
- Patent number 8,961,967
- Issue date Feb 24, 2015
- Janssen Biotech, Inc.
- William Strohl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 8,889,138
- Issue date Nov 18, 2014
- Merck Sharp & Dohme Corp.
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Active protease-resistant antibody FC mutants
- Patent number 8,871,204
- Issue date Oct 28, 2014
- Janssen Biotech, Inc.
- Randall Brezski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized IL-25 antibodies
- Patent number 8,785,605
- Issue date Jul 22, 2014
- Janssen Biotech, Inc.
- Juan Carlos Almagro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IL-13Rα1 antibodies and their uses thereof
- Patent number 8,613,925
- Issue date Dec 24, 2013
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 8,568,722
- Issue date Oct 29, 2013
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL monoclonal antibody and use thereof
- Patent number 8,420,093
- Issue date Apr 16, 2013
- Merck Sharp & Dohme Corp.
- Gene Kinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 8,383,113
- Issue date Feb 26, 2013
- Northwestern University
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody antagonists of interleukin-13 receptor α1
- Patent number 8,207,304
- Issue date Jun 26, 2012
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 8,128,930
- Issue date Mar 6, 2012
- Northwestern University
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL monoclonal antibody and use thereof
- Patent number 8,105,593
- Issue date Jan 31, 2012
- Merck Sharp & Dohme Corp.
- Gene Kinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-addl antibodies and uses thereof
- Patent number 7,811,563
- Issue date Oct 12, 2010
- Northwestern University
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL antibodies and uses thereof
- Patent number 7,780,963
- Issue date Aug 24, 2010
- Merck & Co., Inc.
- Paul Acton
- G01 - MEASURING TESTING
Information Patent Grant
High affinity antibody antagonists of interleukin-13 receptor alpha 1
- Patent number 7,754,213
- Issue date Jul 13, 2010
- Merck & Co., Inc.
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ADDL monoclonal antibody and use thereof
- Patent number 7,731,962
- Issue date Jun 8, 2010
- Merck & Co., Inc.
- Gene Kinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-immunostimulatory antibody and compositions containing the same
- Patent number 7,700,099
- Issue date Apr 20, 2010
- Merck & Co., Inc.
- William R. Strohl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Maxi-k channel blockers, methods of use and process for making the...
- Patent number 7,294,646
- Issue date Nov 13, 2007
- Merck & Co. Inc.
- Maria L. Garcia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...
- Publication number 20230212252
- Publication date Jul 6, 2023
- BioAge Labs, Inc.
- Robert Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING CANCER IN COMBINA...
- Publication number 20220251191
- Publication date Aug 11, 2022
- Arch Oncology, Inc.
- James BLINN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...
- Publication number 20220119480
- Publication date Apr 21, 2022
- BioAge Labs, Inc.
- Robert Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS COMPRISING BCMA-SPECIFIC FIBRONECTIN TYP...
- Publication number 20220031822
- Publication date Feb 3, 2022
- JANSSEN BIOTECH, INC.
- Chen Ni CHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...
- Publication number 20210188940
- Publication date Jun 24, 2021
- BioAge Labs, Inc.
- Robert Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Fc Mutants with Ablated Effector Functions
- Publication number 20210155711
- Publication date May 27, 2021
- Stephen McCarthy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...
- Publication number 20200115435
- Publication date Apr 16, 2020
- BioAge Labs, Inc.
- Robert Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric Antigen Receptors Comprising BCMA-specific Fibronectin Typ...
- Publication number 20190330361
- Publication date Oct 31, 2019
- JANSSEN BIOTECH, INC.
- Chen Ni Chin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antibody Fc Mutants with Ablated Effector Functions
- Publication number 20180319893
- Publication date Nov 8, 2018
- JANSSEN BIOTECH, INC.
- McCarthy Stephen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1
- Publication number 20170369579
- Publication date Dec 28, 2017
- CSL Limited
- Andrew Donald Nash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOC...
- Publication number 20170233461
- Publication date Aug 17, 2017
- NEW YORK UNIVERSITY
- Victor J. TORRES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Fc Mutants with Ablated Effector Functions
- Publication number 20170204193
- Publication date Jul 20, 2017
- JANSSEN BIOTECH, INC.
- William Strohl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1
- Publication number 20160362497
- Publication date Dec 15, 2016
- CSL Limited
- Andrew Donald Nash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antibody Fc Mutants with Ablated Effector Functions
- Publication number 20150337053
- Publication date Nov 26, 2015
- JANSSEN BIOTECH, INC.
- Stephen McCarthy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOC...
- Publication number 20150210756
- Publication date Jul 30, 2015
- NEW YORK UNIVERSITY
- Victor J. Torres
- G01 - MEASURING TESTING
Information Patent Application
ACTIVE PROTEASE-RESISTANT ANTIBODY FC MUTANTS
- Publication number 20150139984
- Publication date May 21, 2015
- JANSSEN BIOTECH, INC.
- Randall Brezski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Fc Mutants with Ablated Effector Functions
- Publication number 20150118227
- Publication date Apr 30, 2015
- JANSSEN BIOTECH, INC.
- William Strohl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1
- Publication number 20140056915
- Publication date Feb 27, 2014
- CSL Limited
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVE PROTEASE-RESISTANT ANTIBODY FC MUTANTS
- Publication number 20130011386
- Publication date Jan 10, 2013
- Randall Brezski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-ADDL Antibodies and Uses Thereof
- Publication number 20120171224
- Publication date Jul 5, 2012
- Merck Sharp & Dohme Corp. and Northwestern University
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-ADDL Monoclonal Antibody and Use Thereof
- Publication number 20120164158
- Publication date Jun 28, 2012
- MERCK SHARP & DOHME CORP.
- GENE KINNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized IL-25 Antibodies
- Publication number 20110318353
- Publication date Dec 29, 2011
- Juan Carlos Almagro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Fc Mutants with Ablated Effector Functions
- Publication number 20110212087
- Publication date Sep 1, 2011
- William Strohl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-ADDL Antibodies and Uses Thereof
- Publication number 20110159013
- Publication date Jun 30, 2011
- Merck & Co., Inc.
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof
- Publication number 20110052597
- Publication date Mar 3, 2011
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Application
High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1
- Publication number 20100285035
- Publication date Nov 11, 2010
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-ADDL Antibodies and Uses Thereof
- Publication number 20100272714
- Publication date Oct 28, 2010
- Paul Acton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-ADDL monoclonal antibody and use thereof
- Publication number 20100239597
- Publication date Sep 23, 2010
- Gene Kinney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Antagonists of Interleukin-13 Receptor Alpha1
- Publication number 20090285799
- Publication date Nov 19, 2009
- Andrew Donald Nash
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Addl Antibodies and Uses Thereof
- Publication number 20080175835
- Publication date Jul 24, 2008
- Merck & Co., Inc.
- Paul Acton
- C07 - ORGANIC CHEMISTRY

William Strohl

Person

Patents Grantslast 30 patents

RAGE fusion proteins with improved stability and ligand binding aff...

Chimeric antigen receptors comprising BCMA-specific fibronectin typ...

RAGE fusion proteins with improved stability and ligand binding aff...

Antibody Fc mutants with ablated effector functions

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Compositions and methods for phagocyte delivery of anti-staphylococ...

Antibody Fc mutants with ablated effector functions

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Compositions and methods for phagocyte delivery of anti-staphylococ...

Antibody Fc mutants with ablated effector functions

Active protease-resistant antibody FC mutants

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Antibody Fc mutants with ablated effector functions

Anti-ADDL antibodies and uses thereof

Active protease-resistant antibody FC mutants

Humanized IL-25 antibodies

Anti-IL-13Rα1 antibodies and their uses thereof

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Anti-ADDL monoclonal antibody and use thereof

Anti-ADDL antibodies and uses thereof

Antibody antagonists of interleukin-13 receptor α1

Anti-ADDL antibodies and uses thereof

Anti-ADDL monoclonal antibody and use thereof

Anti-addl antibodies and uses thereof

Anti-ADDL antibodies and uses thereof

High affinity antibody antagonists of interleukin-13 receptor alpha 1

Anti-ADDL monoclonal antibody and use thereof

Non-immunostimulatory antibody and compositions containing the same

Maxi-k channel blockers, methods of use and process for making the...

Patents Applicationslast 30 patents

RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING CANCER IN COMBINA...

RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...

CHIMERIC ANTIGEN RECEPTORS COMPRISING BCMA-SPECIFIC FIBRONECTIN TYP...

RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...

Antibody Fc Mutants with Ablated Effector Functions

RAGE Fusion Proteins with Improved Stability and Ligand Binding Aff...

Chimeric Antigen Receptors Comprising BCMA-specific Fibronectin Typ...

Antibody Fc Mutants with Ablated Effector Functions

HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1

COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOC...

Antibody Fc Mutants with Ablated Effector Functions

HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1

Antibody Fc Mutants with Ablated Effector Functions

COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOC...

ACTIVE PROTEASE-RESISTANT ANTIBODY FC MUTANTS

Antibody Fc Mutants with Ablated Effector Functions

HIGH AFFINITY ANTIBODY ANTAGONISTS OF INTERLEUKIN-13 RECEPTOR ALPHA 1

ACTIVE PROTEASE-RESISTANT ANTIBODY FC MUTANTS

Anti-ADDL Antibodies and Uses Thereof

Anti-ADDL Monoclonal Antibody and Use Thereof

Humanized IL-25 Antibodies

Antibody Fc Mutants with Ablated Effector Functions

Anti-ADDL Antibodies and Uses Thereof

Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof

High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1

Anti-ADDL Antibodies and Uses Thereof

Anti-ADDL monoclonal antibody and use thereof

Antibody Antagonists of Interleukin-13 Receptor Alpha1

Anti-Addl Antibodies and Uses Thereof